↓ Skip to main content

Cannabis Finds Its Way into Treatment of Crohn's Disease.

Overview of attention for article published in Pharmacology, December 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 584)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
559 tweeters
facebook
138 Facebook pages
googleplus
8 Google+ users
reddit
1 Redditor
video
2 video uploaders

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabis Finds Its Way into Treatment of Crohn's Disease.
Published in
Pharmacology, December 2013
DOI 10.1159/000356512
Pubmed ID
Authors

Rudolf Schicho, Martin Storr, Schicho R, Storr M, Schicho, R., Storr, M.

Abstract

In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases. In a prospective placebo-controlled study, it has been shown what has been largely anticipated from anecdotal reports, i.e. that cannabis produces significant clinical benefits in patients with Crohn's disease. The mechanisms involved are not yet clear but most likely include peripheral actions on cannabinoid receptors 1 and 2, and may also include central actions.

Twitter Demographics

The data shown below were collected from the profiles of 559 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 5%
Canada 1 2%
Unknown 54 93%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 22%
Other 7 12%
Student > Master 7 12%
Student > Ph. D. Student 7 12%
Researcher 7 12%
Other 17 29%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 36%
Medicine and Dentistry 16 28%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Unspecified 5 9%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 8 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 483. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2018.
All research outputs
#13,648
of 11,781,207 outputs
Outputs from Pharmacology
#1
of 584 outputs
Outputs of similar age
#219
of 198,231 outputs
Outputs of similar age from Pharmacology
#1
of 7 outputs
Altmetric has tracked 11,781,207 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 584 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,231 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them